Arkolith/Funds/Investor AB

Investor AB

CIK 889232Holding company
Holdings as of Mar 31, 2026·disclosed May 15, 2026·~45-day 13F lag·13F-HR
Active Filer

Investor AB holds a concentrated book of 10 stocks worth $15.1B as of Q1 2026 (disclosed May 15, 2026, a ~45-day 13F lag). The SEC 13F shows only Investor AB's US-listed positions. Its main portfolio is mostly Stockholm-listed and does not appear in this book. This quarter they opened AstraZeneca PLC and trimmed Coherent Corp. Their largest long position is AstraZeneca PLC at 67% of the equity book.

Build

Build on this 13F portfolio

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Build

Ask your agent what Investor AB owns

This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/funds/889232/holdings"
Ask your agent
Use Arkolith to show INVESTOR AB's latest
holdings, largest changes, and filing provenance.
Opened
4
new positions
Added to
2
existing
Trimmed
2
reduced
Sold out
5
exited

Concentration

Top-heavy: concentrated book

Top 5 holdings
100%
Top 10 holdings
100%
Top 20 holdings
100%

Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.

Direct sector allocation

100% mapped to company sectors

Health Care
67%
Financials
33%
Information Technology
0%
Communication Services
0%

Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.

Biggest moves: latest quarter

Estimated $ traded · quarter-end prices, no cost basis

Bought
Trimmed / exited

Holdings: largest first

Bars show each stock's share of the portfolio. Click a row for its position history.

10 positions
#SecurityValueShares% PortLast moveHistory
1AstraZeneca PLC
ORD
$10.2B51.59M
67.3%
New
New position
2Nasdaq Inc
COM
$4.9B58.38M
32.6%
+0.3%
Added · +200K sh
3Mediwound Ltd
SHS NEW
$14.0M872.1K
0.1%
Held
4Cellebrite Di Ltd
ORDINARY SHARES
$758K55.0K
0.0%
New
New position
5Coherent Corp
COM
$715K3.0K
0.0%
−50%
Reduced · −3K sh
6Kyivstar Group Ltd
ORD SHS
$601K59.4K
0.0%
New
New position
7Verizon Communications Inc
COM
$567K11.3K
0.0%
New
New position
8Corsair Gaming Inc
COM
$553K99.7K
0.0%
−20%
Reduced · −25K sh
9Whirlpool Corp
COM
$253K4.7K
0.0%
+27%
Added · +1K sh
10Biomarin Pharmaceutical Inc
COM
$209K3.7K
0.0%
Held
Showing all 10 positions

Filing history

As-of date vs the date the SEC received each filing

QuarterAs ofFiledPositionsValueForm
Q1 2026Mar 31, 2026May 15, 202610$15.1B13F-HR
Q4 2025Dec 31, 2025Feb 17, 202612$5.7B13F-HR
Q3 2025Sep 30, 2025Nov 14, 202512$5.2B13F-HR
Q2 2025Jun 30, 2025Aug 14, 202513$5.2B13F-HR
Q1 2025Mar 31, 2025May 15, 202513$4.4B13F-HR
Q4 2024Dec 31, 2024Feb 14, 20258$4.5B13F-HR
Q3 2024Sep 30, 2024Nov 14, 20247$4.3B13F-HR
Q2 2024Jun 30, 2024Aug 14, 20246$3.5B13F-HR
Q1 2024Mar 31, 2024May 15, 202410$3.7B13F-HR
Q4 2023Dec 31, 2023Feb 14, 202410$3.4B13F-HR
Q3 2023Sep 30, 2023Nov 14, 20239$2.8B13F-HR
Q2 2023Jun 30, 2023Aug 14, 20239$2.9B13F-HR
Q1 2023Mar 31, 2023May 15, 20237$3.2B13F-HR
Q4 2022Dec 31, 2022Feb 14, 20235$3.6B13F-HR
Q3 2022Sep 30, 2022Nov 14, 20227$3.3B13F-HR
Q2 2022Jun 30, 2022Aug 15, 20225$3.0B13F-HR
Q1 2022Mar 31, 2022May 16, 20228$3.5B13F-HR
Q4 2021Dec 31, 2021Feb 14, 20227$4.1B13F-HR
Q3 2021Sep 30, 2021Nov 15, 20214$3.7B13F-HR
Q2 2021Jun 30, 2021Aug 16, 20213$3.4B13F-HR
Q1 2021Mar 31, 2021May 17, 20212$2.9B13F-HR
Q4 2020Dec 31, 2020Feb 16, 20213$2.6B13F-HR
Q3 2020Sep 30, 2020Nov 16, 20207$2.4B13F-HR
Q2 2020Jun 30, 2020Aug 14, 20204$2.3B13F-HR

Data source

Holdings from SEC EDGAR 13F-HR filings, updated quarterly ~45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. Price-derived performance is withheld until the price-source policy and freshness gate are green.